Internal Medicine Doctors in East Haven, CT Accepting Medicare
5 Internal Medicine doctors found. Showing 1 - 5
 Angelo Accomando, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 Main St, East Haven, CT 06512 Phone: 203-466-5070 Fax: 203-466-4123 |
David Riccio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 310 Main St, East Haven, CT 06512 Phone: 203-467-1800 Fax: 203-468-8343 |
 Dr. Ann Celeste Mapas Dimaya, M.D. Internal Medicine - Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 190 Main St, East Haven, CT 06512 Phone: 203-467-2101 Fax: 203-467-1859 |
Dr. Mark S Kasper, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 339 Hemingway Ave, East Haven, CT 06512 Phone: 203-468-9775 Fax: 203-468-2485 |
Dr. Renzo Renzi, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 205 Main St, East Haven, CT 06512 Phone: 203-405-9005 |
News Archive
AstraZeneca is developing new PARP inhibitor for treatment of ovarian cancer
The ovarian cancer market is highly active with several promising candidates having reached the late stages of development. Three PARP inhibitors, Lynparza (AstraZeneca), niraparib (Tesaro) and rucaparib (Clovis Oncology), which induce cell death in mutated [BRCA-deficient] cancer cells, have been identified by Datamonitor Healthcare as front runners.
"Possible" Smoking ban inside homes: Cancer Council SA
The Cancer Council of South Australia is planning to ban smoking inside Australian apartments and calls this plan "entirely possible and even probable." Earlier this month an eight-unit apartment block in western Sydney introduced a by-law making the premises, including balconies, completely smoke-free.
Discovery of new biomarker for fatal prostate cancer
New research findings out of Wake Forest University School of Medicine and the University of Wisconsin may help provide some direction for men diagnosed with prostate cancer about whether their cancer is likely to be life-threatening.
RaNA Therapeutics completes $20.7 million round of financing
RaNA Therapeutics, Inc. today announced it has completed a $20.7 million round of financing co-led by Atlas Venture, SR One, and Monsanto, with participation of Partners Innovation Fund. The company is developing a technology platform to enable selective activation of target genes and expression of therapeutic factors by targeting a type of regulatory RNA called long non-coding RNA.
On and off-pump coronary artery bypass surgery equally safe, effective for older patients
Older patients did as well after undergoing coronary bypass surgery off-pump as they did with the more costly "on-pump" procedure using a heart-lung machine to circulate blood and oxygen through the body during surgery, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 8 days ago
Internal Medicine
Psychiatry & Neurology
General Practice
Pediatrics
Geriatric Medicine
Endocrinology, Diabetes & Metabolism